#$%^&*AU2020202435A120200507.pdf#####ABSTRACT The present invention provides an epitope peptide that is derived from KOC 1 and that has cytotoxic T cell induction potency. The present invention also provides a 5 polynucleotide that codes for the peptide, antigen-presenting cells that present the peptide and cytotoxic T cells that target the peptide, and a method for inducing the antigenpresenting cells or the cytotoxic T cells. The present invention also provides a composition and a pharmaceutical composition that include the peptide, etc. as active components. The present invention also 10 provides a method for the treatment and/or prevention of cancer and/or the prevention of the post 0 operative recurrence of cancer, the method using the peptide, the polynucleotide, the antigen-presenting cells, and the cytotoxic T cells of the present invention or using the pharmaceutical composition of the present invention. The present invention also provides f a method for inducing an immune response to cancer.
